Research

Clinical spectrum of high-titre GAD65 antibodies February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/33563803/

May is AEA Research Network Month: What is it? May 2, 2022

AEA Research Network Month is when the AE Alliance focuses on research funding, collaborations and AE research awareness. What’s our goal? Raise funds for the 2023 Seed Grant Program. Provide you, the AEA Community a strong understanding of the huge importance of research and AE. What can you expect during May 2022? A better understanding […]

Honoring Ed Arditte – The AEA Edward Arditte Community Seed Grant Program January 26, 2024

Edward C (Ed) Arditte served as board member, Treasurer and was Chairman of the Autoimmune Encephalitis Alliance at the time of his passing in 2023.  Ed was instrumental in the formation of the AE “Medical Advisory Board” as well as the development of the “Community Seed Grant” program.  We are proud to name the program […]

Dr. Russell Dale discusses Autoantibodies in Childhood Encephalitis June 24, 2014

Dr. Russell Dale Associate Professor, Discipline of Paediatrics and Child Health, Sydney Medical School; Consultant Neurologist, the Children’s Hospital at Westmead The Autoimmune Encephalitis Alliance hosted a series of Autoimmune Encephalitis awareness events at Duke University Medical Center, March 26 and 27, 2014.  International experts participated in grand rounds, lectures and panel discussions.  All of the educational videos […]

Autoimmune Encephalitis Alliance co-sponsors pediatric AE treatment consensus meeting December 5, 2016

The Autoimmune Encephalitis Alliance, along with Children’s National Health System, and the Childhood Arthritis and Rheumatology Research Alliance, co-sponsored the first International Pediatric Autoimmune Encephalitis Treatment Consensus Meeting at the Carnegie Endowment for International Peace in Washington, DC, on November 14. “The AE Alliance was honored to help bring many of the world’s leading experts […]

Incidence of AE estimated by Mayo study February 2, 2018

Autoimmune encephalitis experts at the Mayo Clinic published the first population-based study of AE in an effort to determine the incidence of the disease. The researchers found that in the last decade approximately 1 in every 100,000 people develop AE each year. This translates into approximately 4,000 new AE cases in the US annually and […]

Study reveals new insights on NMDAR antibodies November 1, 2018

Physicians conducting research in Barcelona are using high-resolution microscopy and biochemical methods to unlock the secrets surrounding how anti-NMDA receptor antibodies cause disruption at the cellular level, resulting in the alteration of brain function. Dalmau and colleagues have discovered that under laboratory conditions, “NMDARs form nano-objects on the neuronal surface.” Patients with AE have developed […]

Research continues on BBB involvement in AE April 1, 2020

The blood-brain barrier (BBB) is a highly selective barrier formed by endothelial cells connected by tight junctions that separate circulating blood from the brain. An intact BBB prevents many micro- and macromolecules and immune cells from entering the brain in order to protect and maintain an optimal level of essential nutrients and neurotransmitters. There has […]

AEA Community 2021 Seed Grant Program December 10, 2020

The AE Alliance is pleased to announce its inauguration of the AEA Community 2021 Seed Grant Program to support research focused on the diagnosis, management, and outcomes of individuals with AE. We will be awarding multiple grants of $10,000 in 2021. As the name implies, this program is a true community effort. In May 2020 […]